Factors affecting outcome of intracerebral hemorrhage in patients undergoing chronic hemodialysis

Renal Failure

Volumn 32, Issue 8, 2010, Pages 923-927

  Ochiai, Hidenobu ^a   Uezono, Shigehiro ^a   Kawano, Hirokazu ^a   Ikeda, Naoko ^a   Kodama, Keiko ^a   Akiyama, Hiroshi ^a  

^a MIYAZAKI PREFECTURAL MIYAZAKI HOSPITAL   (Japan)

Author keywords

Hemodialysis; Intracerebral hematoma; Prognosis; Renal failure

Indexed keywords

ANTICOAGULANT AGENT; GLYCEROL; HEPARIN; NAFAMSTAT MESILATE; NICARDIPINE;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN EDEMA; BRAIN HEMORRHAGE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HEMATOMA; HEMODIALYSIS; HUMAN; HYPERTENSION; MALE; MORTALITY; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; PROGNOSIS; SYMPTOM; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; BLOOD PRESSURE; CEREBRAL HEMORRHAGE; COHORT STUDIES; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 77955958024     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/0886022X.2010.502279     Document Type: Article

References (20)

1. Ikeda K, Tsuchimochi H, Takeno Y, et al. Clinical analysis of the patients with hemodialysis associated with intracerebral hematoma. No Shinkei Geka. 2004;32:1133-1137.
2. Iseki K, Fukiyama K. Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int. 1996;50:1672-1675.
3. Iseki K, Kawazoe N, Osawa A, et al. Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). Kidney Int. 1993;43: 404-409.
4. Japanese Society for Dialysis Therapy. An overview of regular dialysis treatment in Japan. Tokyo, Japan: Japanese Society for Dialysis Therapy, 2001, pp 78-691.
5. Iseki K, Tozawa M, Iseki C, et al. Clinical demographics and long-term prognosis after stroke in patients on chronic hemodialysis. Nephrol Dial Transplant. 2000;15:1808-1813.
6. Kawamura M, Fujimoto S, Hisanaga S, et al. Incidence, outcome, and risk factors of cerebrovascular events in patients undergoing maintenance hemodialysis. Am J Kidney Dis. 1998;31:991-996.
7. Miyahara K, Murata H, Abe H. Predictors of intracranial hematoma enlargement in patients undergoing hemodialysis. Neurol Med Chir (Tokyo). 2007;47:47-52.
8. Onoyama K, Ibayashi S, Nanishi F, et al. Cerebral hemorrhage in patients on maintenance hemodialysis. CT analysis of 25 cases. Eur Neurol. 1987;26:171-175.
9. Murakami M, Hamasaki T, Kimura S, et al. Clinical features and management of intracranial hemorrhage in patients undergoing maintenance dialysis therapy. Neurol Med Chir (Tokyo). 2004;44:225-233.
10. Noda T, Suzuki S, Miyazaki S, et al. Cerebrovascular disease in chronic hemodialysis patients. J Jpn Soc Dial Ther. 2000;33:1389-1400.
11. Onoyama K, Kumagai H, Miishima T, et al. Incidence of strokes and its prognosis in patients on maintenance hemodialysis. Jpn Heart J. 1986; 27:685-691.
12. Seliger SL, Gillen DL, Longstreth WT, et al. Elevated risk of stroke among patients with end-stage renal disease. Kidney Int. 2003;64:603-609.
13. Seliger SL, Gillen DL, Tirschwell D, et al. Risk factors for incident stroke among patients with end-stage renal disease. J Am Soc Nephrol. 2003;14:2623-2631.
14. Toyoda K, Fujii K, Fujimi S, et al. Stroke in patients on maintenance hemodialysis: A 22-year single-center study. Am J Kidney Dis. 2005;45:1058-1066.
15. Ikeda K, Tsuchimochi H, Fukushima T. Intracerebral hemorrhage of hemodialysis patients. Nippon Rinsho. 2006;64: 542-545.
16. Anderson CS, Huang Y, Wang JG, et al. INTERACT Investigators: Intensive blood pressure reduction in acute cerebral hemorrhage trial (INTERACT): A randomized pilot trial. Lancet Neurol. 2008;7:391-399.
17. Anderson CS, Huang Y, Arima H, et al. INTERACT Investigators: Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: The Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial (INTERACT). Stroke. 2010;41:307-312.
18. Iliopoulou A, Turner P, Warrington SJ. Acute hemodynamic effects of a new calcium antagonist, nicardipine, in man. A comparison with nifedipine. Br J Clin Pharmacol. 1983;15: 59-65.
19. Smith MS, Verghese CP, Shand DG, Pritchett EL. Pharmacokinetic and pharmacodynamic effects of diltiazem. Am J Cardiol. 1983;51:1369-1374.
20. Yang JW, Han BG, Kim BR, et al. Superior outcome of nafamostat mesilate as an anticoagulant in patients undergoing maintenance hemodialysis with intracerebral hemorrhage. Renal Failure. 2009;31:668-675.